Up to 10,000 pregnant French women given epilepsy drug despite risk


Health ministry denies delaying publication of study showing how many women took Sanofi's drug Depakine despite officials knowing dangers.

Reading articles is for subscribers only. Subscribe now.

More than 10,000 pregnant women in France took Sanofi's anti-epilepsy drug Depakine between 2007 and 2014 although the risk of fetus malformation was known, according to a study quoted by French satirical weekly Le Canard Enchaîné, reports Reuters.